Order Article Reprints

Tjong MC, Ragulojan M, Poon I, Louie AV, Cheng SY, Doherty M, Zhang L, Ung Y, Cheung P, Cheema PK. Safety Related to the Timing of Radiotherapy and Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer: A Single Institutional Experience. Current Oncology. 2022; 29(1):221-230. https://doi.org/10.3390/curroncol29010021

Tjong, Michael C., Malavan Ragulojan, Ian Poon, Alexander V. Louie, Susanna Y. Cheng, Mark Doherty, Liying Zhang, Yee Ung, Patrick Cheung, and Parneet K. Cheema. 2022. "Safety Related to the Timing of Radiotherapy and Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer: A Single Institutional Experience" Current Oncology 29, no. 1: 221-230. https://doi.org/10.3390/curroncol29010021

Tjong, M. C., Ragulojan, M., Poon, I., Louie, A. V., Cheng, S. Y., Doherty, M., Zhang, L., Ung, Y., Cheung, P., & Cheema, P. K. (2022). Safety Related to the Timing of Radiotherapy and Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer: A Single Institutional Experience. Current Oncology, 29(1), 221-230. https://doi.org/10.3390/curroncol29010021